About
About SunWay Biotech
Milestones
Managing Team
Ingredient
ANKASCIN® 568
Vigiis® 101-LAB
MonaFit™
ExoBDNF™
XtraMyo™
Vigiis® 101 For Pets
PawEnergia™
CDMO
CDMO Service Overview
Ingredient Development & Manufacturing
Custom Solutions
Quality & Regulatory Support
Investors
Dealership
News
All
Business
Events
Investors
Community
Awards
Contact
About
About SunWay Biotech
Milestones
Managing Team
Ingredient
ANKASCIN® 568
Vigiis® 101-LAB
MonaFit™
ExoBDNF™
XtraMyo™
Vigiis® 101 For Pets
PawEnergia™
CDMO
CDMO Service Overview
Ingredient Development & Manufacturing
Custom Solutions
Quality & Regulatory Support
Investors
Dealership
News
All
Business
Events
Investors
Community
Awards
Contact
EN
Home
>
Investors
Investors
Discover our latest news and milestones as we move health forward.
All
Business
Events
Investors
Community
Awards
Investors
01.14.2021
SunWay 2020 annual revenue was 314 million and will be listed on Taiwan Emerging Stock Market on January 18, 2021.
